MetLife Investment Management’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Hold |
16,329
| – | – | ﹤0.01% | 2494 |
|
|
2025
Q1 | $148K | Hold |
16,329
| – | – | ﹤0.01% | 2357 |
|
|
2024
Q4 | $282K | Buy |
16,329
+1,731
| +12% | +$29.9K | ﹤0.01% | 2116 |
|
|
2024
Q3 | $233K | Hold |
14,598
| – | – | ﹤0.01% | 2209 |
|
|
2024
Q2 | $208K | Buy |
14,598
+2,904
| +25% | +$41.4K | ﹤0.01% | 2217 |
|
|
2024
Q1 | $166K | Hold |
11,694
| – | – | ﹤0.01% | 2298 |
|
|
2023
Q4 | $176K | Hold |
11,694
| – | – | ﹤0.01% | 2304 |
|
|
2023
Q3 | $185K | Hold |
11,694
| – | – | ﹤0.01% | 2263 |
|
|
2023
Q2 | $177K | Buy |
+11,694
| New | +$177K | ﹤0.01% | 2352 |
|